|
Evidence
|
Type
|
Description
|
Points
|
Association Score (AS)
|
Association study
|
p value |
<0.05 |
0.5 |
<0.001 |
1 |
<0.00001 |
1.5 |
|
Maximum Allowable Sum of Points for Association Score
|
8
|
Variant Score (VS) |
Genetic variants
|
Number of variants |
One point for each variant in every phenotype stored in IthaGenes. |
1 |
|
Maximum Allowable Sum of Points for Variant Score
|
20
|
Experimental Score (ES)
|
Function
|
Biochemical Function |
Functions are shared between gene products involved in the same disease phenotype. |
1 |
Protein Interaction |
Gene product interacts with proteins previously implicated in the disease phenotype. Gene defect disrupting protein interactions. |
1 |
Expression |
Gene is expressed in tissues relevant to the disease phenotype. Altered gene expression in patients. |
1 |
Functional Alteration
|
Cells from affected individual |
Function of gene product is altered in individuals/engineered cells with candidate mutations (altered expression levels, splicing or normal biochemical function). |
1.5 |
Engineered cells |
1.5 |
Model Systems
|
Animal model |
Introduction of the variant or an engineered gene product carrying the variant in a non-human animal model/cell-culture model displays the disease phenotype. |
2 |
Cell culture model system |
2 |
Rescue
|
Rescue in non-human model organism |
Addition of the wild-type gene product or specific knockdown of the variant allele can rescue the disease phenotype in a non-human model organism/cell-culture model/patient. |
2 |
Rescue in cell culture model |
2 |
Rescue in patients |
2 |
|
Maximum Allowable Sum of Points for Experimental Score
|
6
|